Director PFENNIGER RICHARD C JR 🟢 acquired 16.4K shares (1 derivative) of Cocrystal Pharma, Inc. (COCP) at $1.10 Transaction Date: Jan 09, 2026 | Filing ID: 002042
Wagner Paul A. 🟢 acquired 450.0K shares (2 derivative) of Forte Biosciences, Inc. (FBRX) at $29.66 ($8.0M) Transaction Date: Jan 12, 2026 | Filing ID: 000004
Director Hassan Fred 🟢 acquired 16.4K shares (1 derivative) of Cocrystal Pharma, Inc. (COCP) at $1.10 Transaction Date: Jan 09, 2026 | Filing ID: 002037
Martin James Joseph 🟢 acquired 49.2K shares (1 derivative) of Cocrystal Pharma, Inc. (COCP) at $1.10 Transaction Date: Jan 09, 2026 | Filing ID: 002036
Director FROST PHILLIP MD ET AL 🟢 acquired 24.6K shares (1 derivative) of Cocrystal Pharma, Inc. (COCP) at $1.10 Transaction Date: Jan 09, 2026 | Filing ID: 002035
Director Japour Anthony J 🟢 acquired 16.4K shares (1 derivative) of Cocrystal Pharma, Inc. (COCP) at $1.10 Transaction Date: Jan 09, 2026 | Filing ID: 002034
Director Rubin Steven D 🟢 acquired 16.4K shares (1 derivative) of Cocrystal Pharma, Inc. (COCP) at $1.10 Transaction Date: Jan 09, 2026 | Filing ID: 002033